Can a sufficient quantity of prescription drugs be safely imported from Canada to help reduce costs for taxpayers and people with low and moderate incomes?
That was the question addressed by nine experts, elected officials, and business leaders at the National Symposium on Drug Importation, held in Chicago in October 2003. All presentations from the conference were transcribed and are published here, edited with the speakers’ permission, so everyone can better understand what is at stake in this debate. The speakers’ presentations were titled:
* Not a Solution to State Budget Problems
* The Danger of Unknown and Unknowable Costs
* Small Gains, Enormous Risks
* The Dubious Economics of Drug Importation
* A Canadian Economist’s Perspective
* Don’t Just Stand There, Do Something!
* Costs, Compulsory Licensing, and Counterfeiting
* It’s Really About Spending, Not Safety
* Summary: The Pros and Cons of Drug Importation
Bonus chapters:
* Blagojevich’s $91 Million Mistake
* Letter from the FDA to the State of Illinois
Details
July 2018
90 pages
ISBN 13-978-1-934791-71-4
Availability
A Kindle edition is available at Amazon.com.
The full book is also available for free in PDF format.
